Skip to main content
. Author manuscript; available in PMC: 2016 Mar 21.
Published in final edited form as: Semin Cell Dev Biol. 2015 Aug 12;43:22–32. doi: 10.1016/j.semcdb.2015.08.002

Table 1.

Alteration of amino acid management pathways in cancer.

Amino acid metabolism

Gene Function Cancer alteration/relevance References

GLS Rate limiting step in glutaminolysis Increased translational efficiency downstream of MYC, miR-23a/b [58]
PHGDH Rate limiting step in serine biosynthesis Genomic amplification and over-expression [23,24]
SHMT2 Diversion of serine into mitochondrial one-carbon metabolism Over-expression, drives hypoxia resistance [23,35,36]
GLDC Key component of the glycine cleavage complex Prevents toxic glycine accumulation, drives broad metabolic changes [36,42]
ASNS Asparagine biosynthesis Increased expression in glioblastoma [65]
Amino acid sensing

Gene Function Cancer alteration/relevance References

mTOR Protein kinase, controls translation in response to nutrient sufficiency signals Activating point mutations, amino acid starvation fails to inactivate mTORC1 [120,155]
FLCN mTORC1 positive regulator, GTPase activating protein for RAG C/D Loss of function mutations in Birt–Hogg–Dubé syndrome [105107]
DEPDC5 GATOR1 component, negative regulator of mTORC1, GTPase activating protein for RAG A/B Deletion of 22q12.2, amino acid starvation fails to inactivate mTORC1 [116,117]
NPRL2 GATOR1 component, negative regulator of mTORC1, GTPase activating protein for RAG A/B Deletion of 3p21.3, amino acid starvation fails to inactivate mTORC1 [116,118,119]